Reproducibility of visual assessment on mammographic density.
ABSTRACT High mammographic density was an independent risk factor for breast cancer and has a higher associated risk than most other known risk factors. The reproducibility remains a major issue in assessment of breast parenchymal patterns. Misclassification of mammographic pattern can lead to significant underestimation of risk estimates. The purpose of this study was to assess the inter-rater and intra-rater reliability based on visual subjective mammographic density measurements.
Three density measures, Wolfe parenchymal pattern, Boyd classification scale, and a percentage of densities in total breast, were investigated. The study included 101 women who were participants of the International Breast Cancer Intervention Study I (IBIS I) for up to 7 years. Seven sets of mammograms were collected for each woman. Left breast mediolateral oblique films were digitized, and the scanned images were independently reviewed by two readers. These images were reassessed by one reader after a year. The agreements of measures were evaluated by Kappa statistics (Wolfe and Boyd scale) and intraclass correlation coefficient (percentage densities).
For the inter-rater agreement, Weighted Kappa for Wolfe scale was 0.89 (P < 0.0001) and for Boyd scale was 0.84 (P < 0.0001). The intraclass correlation coefficient was 0.94 for percentage densities. For the intra-rater agreement, Weighted Kappa for Wolfe scale was 0.87 (P < 0.0001) and for Boyd scale was 0.86 (P < 0.0001). The intraclass correlation coefficient was 0.96 for percentage densities.
The study concludes that both visual qualitative and quantitative measurements on mammographic density are highly reproducible in the breast cancer research studies if appropriate training is provided. The method is appropriate for risk assessment in a prevention trial.
Article: Independent association of lobular involution and mammographic breast density with breast cancer risk.[show abstract] [hide abstract]
ABSTRACT: Lobular involution, or age-related atrophy of breast lobules, is inversely associated with breast cancer risk, and mammographic breast density (MBD) is positively associated with breast cancer risk. To evaluate whether lobular involution and MBD are independently associated with breast cancer risk in women with benign breast disease, we performed a nested cohort study among women (n = 2666) with benign breast disease diagnosed at Mayo Clinic between January 1, 1985, and December 31, 1991 and a mammogram available within 6 months of the diagnosis. Women were followed up for an average of 13.3 years to document any breast cancer incidence. Lobular involution was categorized as none, partial, or complete; parenchymal pattern was classified using the Wolfe classification as N1 (nondense), P1, P2 (ductal prominence occupying <25%, or >25% of the breast, respectively), or DY (extremely dense). Hazard ratios (HRs) and 95% confidence intervals (CIs) to assess associations of lobular involution and MBD with breast cancer risk were estimated using adjusted Cox proportional hazards model. All tests of statistical significance were two-sided. After adjustment for MBD, having no or partial lobular involution was associated with a higher risk of breast cancer than having complete involution (none: HR of breast cancer incidence = 2.62, 95% CI = 1.39 to 4.94; partial: HR of breast cancer incidence = 1.61, 95% CI = 1.03 to 2.53; P(trend) = .002). Similarly, after adjustment for involution, having dense breasts was associated with higher risk of breast cancer than having nondense breasts (for DY: HR of breast cancer incidence = 1.67, 95% CI = 1.03 to 2.73; for P2: HR of breast cancer incidence = 1.96, 95% CI = 1.20 to 3.21; for P1: HR of breast cancer incidence = 1.23, 95% CI = 0.67 to 2.26; P(trend) = .02). Having a combination of no involution and dense breasts was associated with higher risk of breast cancer than having complete involution and nondense breasts (HR of breast cancer incidence = 4.08, 95% CI = 1.72 to 9.68; P = .006). Lobular involution and MBD are independently associated with breast cancer incidence; combined, they are associated with an even greater risk for breast cancer.CancerSpectrum Knowledge Environment 10/2010; 102(22):1716-23. · 14.07 Impact Factor